Polar Capital Holdings’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,236,609
Closed -$147K 489
2022
Q1
$147K Sell
1,236,609
-47,971
-4% -$5.69K 0.66% 23
2021
Q4
$177K Buy
1,284,580
+28,108
+2% +$3.87K 0.66% 26
2021
Q3
$175K Buy
1,256,472
+360,740
+40% +$50.1K 0.71% 23
2021
Q2
$87K Buy
895,732
+33,905
+4% +$3.29K 0.38% 60
2021
Q1
$58.9M Buy
861,827
+59,300
+7% +$4.05M 0.36% 80
2020
Q4
$68.8M Buy
+802,527
New +$68.8M 0.42% 68